Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04701918
Title Pembrolizumab And Cryoablation In Urothelial Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

transitional cell carcinoma

urethra transitional cell carcinoma

ureter transitional cell carcinoma



Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.